Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: Randomized controlled trial design and protocol

BMC Psychiatry

Volumn 11, Issue , 2011, Pages

  Bockting, Claudi L H ^a   Kok, Gemma D ^a   Kamp, Lillian V D ^b   Smit, Filip ^b,c   van Valen, Evelien ^d   Schoevers, Robert ^e   van Marwijk, Harm ^c   Cuijpers, Pim ^f   Riper, Heleen ^c   Dekker, Jack ^f,g   Beck, Aaron T ^h  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f VU UNIVERSITY AMSTERDAM   (Netherlands)

^g Arkin Mental Health Care   (Netherlands)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ECONOMIC EVALUATION; EMPOWERMENT; FOLLOW UP; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; INTERNET; MAJOR DEPRESSION; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; SELF CARE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SYMPTOM; SYMPTOMATOLOGY; TELEMONITORING; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEPRESSION; ECONOMICS; METHODOLOGY; NETHERLANDS; TELEMEDICINE; TREATMENT OUTCOME;

CLINICAL PROTOCOLS; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; HUMANS; NETHERLANDS; RECURRENCE; RESEARCH DESIGN; SELF CARE; TELEMEDICINE; TREATMENT OUTCOME;

EID: 78651361776     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-11-12     Document Type: Article

References (45)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:442.
2. Murray CJ, Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet 1997, 349:1347-52. 10.1016/S0140-6736(96)07494-6, 9149696.
3. Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatr 2004, 61:1097-103. 10.1001/archpsyc.61.11.1097, 15520357.
4. Beck AT. The current state of cognitive therapy: a 40-year retrospective. Arch Gen Psychiatry 2005, 62:953-9. 10.1001/archpsyc.62.9.953, 16143727.
5. Vittengl JR, Clark LA, Dunn TW, Jarrett RB. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol 2007, 75:475-88. 10.1037/0022-006X.75.3.475, 2630051, 17563164.
6. Bockting CLH, Schene AH, Spinhoven P, Koeter MWJ, Wouters LF, Huyser J, Kamphuis JH. Preventing recurrence in recurrent depression using cognitive therapy. J Cons Clin Psychol 2005, 73:647-657.
7. Bockting CLH, Spinhoven P, Koeter MWJ, Schene AH. Long term effects of preventive cognitive therapy in recurrent depression using: 5.5 years follow-up. J Clin Psychiatry 2009, 70:1621-8. 10.4088/JCP.08m04784blu, 20141705.
8. Wright JH, Wright AS, Albano AM, Basco MR, Goldsmith LJ, Raffield T, Otto MW. Computer-assisted cognitive therapy for depression: maintaining efficacy while reducing therapist time. Am J Psychiatry 2005, 162:1158-64. 10.1176/appi.ajp.162.6.1158, 15930065.
9. Spek V, Cuijpers P, Nykliček I, Riper H, Keyzer J, Pop V. Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta analyse. Psychol Med 2007, 37:319-328. 10.1017/S0033291706008944, 17112400.
10. American Psychiatric Association Practice guidelines for the treatment of psychiatric disorders: Compendium 2008, Washington, D.C, American Psychiatric Association.
11. Clinical NICE Depression Management of depression in primary and secondary care 2009, The National Collaborating Centre for Mental Health, December, Clinical NICE Depression.
12. Frank E, Kupfer DJ, Perel JM, Cornes C, Jarret JB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990, 47:1093-1099.
13. Bockting CLH, Spinhoven P, Koeter MW, Wouters LF, Schene AH, . the DELTA study group Prediction of recurrence in recurrent depression and the influence of consecutive episodes on vulnerability: a 2-year prospective study. J Clin Psychiatry 2006, 67(5):747-755. 10.4088/JCP.v67n0508, 16841624, the DELTA study group.
14. Bockting CLH. Preventive cognitive therapy for recurrent depression 2009, Houten: Bohn Stafleu van Loghum.
15. Bockting CLH, Valen van E. Ingredients of Mobile Preventive Cognitive therapy for recurrent depression 2009, Groningen University. The Netherlands.
16. Beck A, Rush A, Shaw B, Emery G. Cognitive therapy of depression 1979, New York: Guilford Press.
17. Pollock LR, Williams JMG. Effective problem solving in suicide attempters depends on specific autobiographical recall. Suicide and Life Threatening Behavior 2001, 31:386-396. 10.1521/suli.31.4.386.22041, 11775714.
18. Harley R, Papakostas GI, Montoya HD, Fava M, Alpert JE. Continuation cognitivebehavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine. Psychological Medicine 2004, 34:555-61. 10.1017/S0033291703001028, 15259840.
19. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychological Medicine 1996, 26:477-86. 10.1017/S0033291700035558, 8733206.
20. First MB, Gibbon M, Spitzer RL, Williams JBW. User Guide for the Structured Clinical Interview for DSM-IV Axis 1 Disorders 1996, Washington, DC: American Psychiatric Association.
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62. 10.1136/jnnp.23.1.56, 495331, 14399272.
22. Hakkaart-van Roijen L, van Straten A, Donker M, Tiemens B. Instituut voor Medische Technology Assessment, Erasmus Universiteit Rotterdam. Handleiding Trimbos/iMTA questionnaire for Costs associated with Psychiatric illness (TiC-P), Rotterdam 2002,
23. de Graaf R, Bijl RV, Ravelli A, Smit F, Vollebergh WAM. Nemesis somatic illnesses list. Predictors of first incidence of DSM-III-R psychiatric disorders in the general population: findings from the Netherlands Mental Health Survey and Incidence Study. Acta Psychiatr Scand 2002, 106:303-313. 10.1034/j.1600-0447.2002.01397.x, 12225498.
24. Kraaij V, De Wilde EJ. Negative life events and depressive symptoms in the elderly: A life span perspective. Aging and Mental Health 2001, 5:84-91. 10.1080/13607860020020681, 11513018.
25. Franck E, De Raedt R, Barbez C, Rosseel Y. Psychometric properties of the Dutch Rosenberg self-esteem scale. Pscyhologica Belgica 2008, 4:25-35.
26. Akkerhuis GW, Kupka RW, van Groenestijn MAC, Nolen WA. PDQ-4+ Vragenlijst voor persoonlijkheidskenmerken 1996, Lisse: Swets & Zeitlinger.
27. Vingerhoets AJJM, van Tilburg MAL. Everyday Problem Checklist (EPCL) 1994, Lisse: Swets & Zeitlinger B.V.
28. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, Skeppar P, Vieta E, Scott J. Towards the self-assessment tool for hypomanic symptoms in outpatients. J Affective Disorders 2005, 88:217-233.
29. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a selfreported measure of medication adherence. Med.Care 1986, 24:67-74. 10.1097/00005650-198601000-00007, 3945130.
30. EuroQol Group EuroQol a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. 10.1016/0168-8510(90)90421-9, 10109801, EuroQol Group EuroQol.
31. Treynor W, Gonzalez R, Nolen-Hoeksema S. Rumination reconsidered: A psychometric analysis. Cogn Therapy Res 2003, 27:247-259.
32. Weissman AN. The Dysfunctional Attitude Scale. Academic dissertation University of Pennsylvania; 1979 (Dissertation Abstracts International: 40, 1389B-1390B).
33. Van der Does W. Cognitive reactivity to sad mood: structure and validity of a new measure. Behav Res Ther 2002, 40:105-20. 10.1016/S0005-7967(00)00111-X, 11762423.
34. Hayes SC, Strosahl K, Wilson KG, Bissett RT, Pistorello J, Toarmino D, Polusny MA, Dykstra TA, Batten SV, Bergan J, Stewart SH, Zvolensky MJ, Eifert GH, Bond FW, Forsyth JP, Karekla M, Mccurry SM. Measuring Experiential Avoidance: A preliminary test of a working model. Psychol Record 2004, 54:553-578.
35. Schreurs PJG, Willige van den G, Brosschot JF, Tellegen B, Graus GMH. Herziene handleiding De Utrechtse Coping Lijst: UCL 1993 Omgaan met problemen en gebeurtenissen Lisse: Swes & Zeitlinger.
36. Master Pearlin LI, Schooler I. The structure of coping. J Health Soc Behav 1981, 19:2-21.
37. Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry 2000, 31:73-86. 10.1016/S0005-7916(00)00012-4, 11132119.
38. De Graaf EL, Huibers MJH, Riper H, Gerhards SAH, Arntz A. Use and acceptability of unsupported online computerized cognitive behavioral therapy for depression and associations with clinical outcome. J Affect Disord 2009, 116:227-231. 10.1016/j.jad.2008.12.009, 19167094.
39. Greenwald AG, McGhee DE, Schwartz JLK. Measuring individual differences in implicit cognition. The Implicit Association Test. J Personality Social Psychol 1998, 74:1464-1480.
40. Koster EHW, De Raedt R, Verschuere B, Tibboel H, de Jong PJ. Enhanced emotion induced attentional blink for negative information in dysphoria. Depression and Anxiety 2009, 26:E16-E22. 10.1002/da.20420, 19031465.
41. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA. Manual for Costing: Methods and standard costs for economic evaluations in health care 2004, Diemen: Health Insurance Board.
42. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Standardisation of costs: the Dutch manual for costing in economic evaluations. PharmacoEconomics 2002, 20:443-54. 10.2165/00019053-200220070-00002, 12093300.
43. Langley PC. The November 1995 revised Australian Guidelines for the economic evaluation of pharmaceuticals. Pharmacoeconomics 1996, 9:341-352. 10.2165/00019053-199609040-00007, 10160108.
44. Torrance GW, Blaker D, Detsky A, Kennedy W, Schubert F, Menon D, Tugwell P, Konchak R, Hubbard E, Firestone T. Canadian guidelines for economic evaluation of pharmaceuticals. Pharmacoeconomics 1996, 9:535-559. 10.2165/00019053-199609060-00008, 10160481.
45. Brower WBF, Koopmanschap MA, Rutten FFH. Productivity losses without absence: measurement validation and empirical evidence. Health Policy 1999, 48:13-27. 10.1016/S0168-8510(99)00028-7, 10539583.